April 03, 2021
1 min read
Save
Eight important updates for Head and Neck Cancer Awareness Month
April is Head and Neck Cancer Awareness Month.
The observance is intended to raise awareness about these types of malignancies and the need for more effective therapies.
In conjunction with this campaign, Healio and HemOnc Today present the following updates in head and neck cancer research and treatment.
- Living in an area with higher levels of outdoor artificial nighttime light appeared associated with higher risk for developing thyroid cancer. Read more.
- De-escalated intensity-modulated radiotherapy plus concurrent cisplatin satisfied criteria for further study among patients with HPV-related oropharyngeal squamous cell carcinoma. Read more.
- Thyroid cancer incidence and mortality patterns among children and adolescents worldwide mirror data for adults, suggesting overdiagnosis and a need to explicitly recommend against screening for the disease in asymptomatic children. Read more.
- GERD appeared to increase risk for laryngeal squamous cell carcinoma and other malignancies. Read more.
- The addition of stereotactic body radiation therapy to nivolumab (Opdivo, Bristol Myers Squibb) did not improve outcomes among a cohort of patients with metastatic head and neck squamous cell carcinoma. Read more.
- Adults with differentiated thyroid cancer had greater likelihood for severe COVID-19 outcomes with older age and at least one comorbidity; however, cancer-related factors did not increase risks. Read more.
- The combination of an investigational cell therapy using tumor-infiltrating lymphocytes and pembrolizumab (Keytruda, Merck) induced responses among a small cohort of patients with metastatic head and neck squamous cell carcinoma. Read more.
- Transoral robotic surgery appeared associated with improved surgical and long-term survival outcomes compared with nonrobotic surgery for patients with early-stage oropharyngeal cancer. Read more.